Talquetamab-Tgvs
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Targeting GPRC5D With Talquetamab: A New Frontier in Bispecific Antibody Therapy for Relapsed/Refractory Multiple Myeloma.
Journal: The Annals of pharmacotherapy
Published: August 28, 2024
Talquetamab (Talvey) for multiple myeloma.
Journal: The Medical letter on drugs and therapeutics
Published: September 08, 2023
"A beacon of hope for relapsed multiple myeloma patients: TALVEY™".
Journal: Rare tumors
Published: September 05, 2023
Showing 1-6 of 6
Last Updated: 11/08/2026